Sensipar Cinacalcet Hydrochloride Tablets AntitrusIn re: Sensipar Cinacalcet Hydrochloride Tablets Antitrus
In re: SENSIPAR CINACALCET HYDROCHLORIDE TABLETS ANTITRUST LITIGATION |
AMGEN INC, TEVA PHARMACEUTICALS USA INC, WATSON LABORATORIES INC and ACTAVIS PHARMA INC |
CESAR CASTILLO LLC, KPH HEALTHCARE SERVICES INC, TEAMSTERS WESTERN REGION & LOCAL 177 HEALTH CARE PLAN, UFCW LOCAL 1500 WELFARE FUND, TEAMSTERS LOCAL 237 WELFARE FUND and TEAMSTERS LOCAL 237 RETIREES BENEFIT FUND |
23-8020 |
April 17, 2023 |
U.S. Court of Appeals, Third Circuit |
Other |
Docket Report
This docket was last retrieved on April 17, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 1 Petition for Permission to Appeal under 28 U.S.C. Section 1292(b) filed by Petitioners Actavis Pharma Inc, Amgen Inc, Teva Pharmaceuticals USA Inc and Watson Laboratories Inc. Received on 04/17/2023. Certificate of Service dated 04/17/2023. Service made by ECF, Email. (JK) [Entered: 04/20/2023 10:20 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.